As RevMed preps for ‘historic’ pancreatic cancer launch, questions linger on the ground

Ajaz Khan, M.D., a medical oncologist at City of Hope Chicago, was in the packed audience at this summer’s American Society of Clinical Oncology meeting when Revolution Medicines received a standing ovation for its groundbreaking pancreatic cancer data.